Ravi Salgia to Retreatment
This is a "connection" page, showing publications Ravi Salgia has written about Retreatment.
Connection Strength
0.194
-
Managing Patients With Relapsed Small-Cell Lung Cancer. J Oncol Pract. 2018 06; 14(6):359-366.
Score: 0.161
-
Phase II Study of the AKT Inhibitor MK-2206 plus Erlotinib in Patients with Advanced Non-Small Cell Lung Cancer Who Previously Progressed on Erlotinib. Clin Cancer Res. 2015 Oct 01; 21(19):4321-6.
Score: 0.033